Medical Writing Services
Ruver Technologies is a global partner for strategic development and
commercialization in the pharmaceutical, biotechnology, and medical device
industries. Development strategy, regulatory/risk planning & management, clinical
research, medical/scientific support, and developing region expansion benefit from
our experience, initiatives, and processes.
- We offer End-to-End CEP and CER writing services following MEDDEV 2.7/1 Rev.4 guidelines and Medical Device Regulation (MDR).
- We develop CEP and CER templates and tailored them as per client requirements.
- We prepare a GAP assessment checklist and perform GAP analysis for existing CER and provide recommendations following MEDDEV 2.7/1 Rev.4 guidelines and Medical Device Regulation (MDR).
- We can handle the periodic update of existing CER as per MEDDEV 2.7/1 Rev.4 guidelines and Medical Device Regulation (MDR).
- We present an in-depth clinical data analysis taken from clinical investigations and literature search results.
- We can provide Systematic Literature Review (SLR) services. Our Medical Information Specialists will design a comprehensive literature search protocol, with complete documentation of the literature screening and data extraction process. QC reviewers ensure the document is scientifically sound, accurate and adheres to current guidelines and client internal structure.
- We summarize the State of the Art background and maturity of current technology for your device.
- We can establish a strong Equivalence argument (if needed)
- We can provide clear summaries of Post Market Surveillance (PMS) data, Risk-Benefit analysis, and Post Market Clinical Follow-Up (PMCF).
Invitro Diagnostics
With our experienced medical writers:
- Technical documentation and declaration of conformity as per IVDR 2017/746
- We can develop Scientific validity reports, clinical performance reports, analytical performance reports, performance evaluation plan and performance evaluation reports
With our experienced medical writers:
- We offer ICH GCP compliant Clinical Study Reports (CSRs); Phases I to IV, including CSR Synopses for public disclosure
- We can prepare Study Protocols
- We can develop Clinical and non-clinical sections of the Common Technical Document (CTD) including summaries and overviews for EU or US Regulatory Authorities
- We can develop Investigator Brochures, Patient safety narratives, Patient information including Informed Consent and Patient Brochures
- We can provide pharmacovigilance documents such as Periodic Safety Update Reports
To extend support the activities/tasks related with development of Health Economics & Outcomes Research/ Health Technology Assessment (HTA) related documents. Our services include:
- Evidence Synthesis
- Modelling for HTA submissions
- Systematic literature review and update
- Local adaptations of global models
- Targeted literature review
- Unmet needs and disease burden
- Meta-analysis and Network meta-analysis
- Manuscript writing
- Risk of bias assessments
- Global value dossiers preparation
- Database mapping studies to identify data sources for RWE studies
- Conference abstracts writing and poster design
- Health Economic Modelling
- Publication planning and assistance
- Cost-effectiveness analyses
- Budget impact analyses
- Slide sets
- Utility research (resource and cost estimation)
Our delivery models are driven by a scientifically sound team to promote publishing strategy, planning, management and implementation.
- To drive publication strategy, plan management, and execution, we have a team of professional medical authors and publication managers with a strong scientific background.
- Our scientific team is backed up by an experienced account and project management team that ensures that all strategic communication strategies and tactics are completed on time and on budget.
- By employing transformative delivery and engagement methods, we can assist our clients in achieving their internal efficiency and cost-cutting goals.
- We can provide:
- Global and regional publication strategy and plans
- Primary and secondary manuscripts, narrative reviews, and systematic reviews
- Abstracts, posters, oral presentations, and competitive intelligence, and Congress support
- Editorial and fact check support
- DataVisionTM support
- Multichannel tactics (digital posters, video abstracts, author videos, etc.)
Ruver Technologies pharmacovigilance services are highly configurable and detail-oriented,
intending to ensure patient safety and product quality. Experts on our team have worked on
clinical trials and post-marketing safety surveillance for various pharmaceutical,
biotechnology, and medical device firms worldwide. Ruver Technologies' team of highly trained
and qualified professionals collaborates fluidly across therapeutic areas to ensure the
successful delivery of pharmacovigilance services to our customers. At an extraordinary level of
quality, we assess, analyze, and evaluate the safety profile of the products using the best
industry methods. Ruver Technologies justifies every service across the entire process, from
pre-marketing to post-marketing pharmacovigilance efforts to support services.